Invitation to Immunovia’s Q1 presentation
Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET.
Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET.
Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement with balloon-expandable valves.
Ribbon Biolabs, the DNA synthesis company, announced its participation in the SynBioBeta 2023 conference, held from May 23 to May 25, 2023, in Oakland, CA.
En este Short os contamos dónde y en qué medida se produjo la lluvia más intensa en el mundo. …
La lluvia mas intensa jamás registrada en el mundo Read More »
Unos ingenieros han desarrollado una esponja que puede retirar del agua el plomo, un metal pesado tóxico que históricamente ha causado muchos problemas en el agua destinada al consumo humano. El agua contaminada con plomo, una vez tratada con esta esponja, pierde su plomo y pa …
Clarivate Plc, a global leader in connecting people and organizations to intelligence they can trust to transform their world, released its new report, Biopharma Dealmaking in 2023.
Ochre Bio, an innovator in chronic liver disease medicine development, announced the appointment of Eliot Forster, Ph.D. as Chairperson of the Board of Directors.
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors Read More »
Royal Philips, a global leader in health technology, announced the launch of the Philips CT 3500, a new high-throughput CT system targeting the needs of routine radiology and high-volume screening programs.
BioArctic AB’s partner Eisai announced the publication of results from a simulation study evaluating the societal value of lecanemab, an investigational anti-amyloid beta protofibril antibody, for the treatment of early Alzheimer’s disease, in the context of the Japanese health care system in the peer-reviewed journal Neurology and Therapy.
Societal value of lecanemab in Japan published in Neurology and Therapy Read More »
Pfizer Inc. announced the pricing of a debt offering consisting of eight tranches of notes.